Summerset Group Holdings Ltd (ASX:SNZ) profit up 26%

Summerset Group Holdings Ltd (ASX: SNZ) has advised its underlying profit for the six months to June 30 2018 will rise

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

New Zealand retirement home and hospital group Summerset Group Holdings Ltd (ASX: SNZ) has advised its underlying profit for the six months to June 30, 2018, will be up between 21% and 26% on the previous corresponding period.

According to an earnings guidance announcement today, Summerset will report underlying profit of between NZ$43 million and NZ$45 million for the period off the back of "strong development margins" on settled homes over the first half.

Sales and resales volumes are also on track with full financial results to be handed down on August 14.

On home soil companies intending to cash in on the ageing population include Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) which has been having a tough time of late as its share price tumbled to multi-year lows off the back of challenging industry dynamics and private health insurance declines.

Goldman Sachs placed a sell rating on Ramsay earlier this month, but many investors keen on its growth prospects in the private hospital sector might see it as hovering in buy territory.

Healthscope Ltd (ASX: HSO) shares have also tumbled into the red of late, down 0.2% to $2.24 at the time of writing.

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Scientists in a laboratory look at a computer screen with anticipation on their faces.
Healthcare Shares

Down 30% today, is it time to buy into this beaten-down biotech share?

While there's been bad news, this company has more irons in the fire.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

What's the impact of US tariffs on Aussie drugmakers CSL and Mayne Pharma?

Is the US' bark worse than its bite?

Read more »

Health professional working on his laptop.
Healthcare Shares

Mesoblast shares are back in the red on Tuesday. Here's why

Mesoblast shares slip despite another strong quarterly sales update from Ryoncil.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Earnings Results

Why are Telix shares jumping 8% today?

The radiopharmaceuticals company's shares are starting the week strongly.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Mesoblast shares: Ryoncil® underpins strong earnings growth

Mesoblast shares are in focus as Ryoncil® delivers nearly US$100m in sales since launch, fueling future growth initiatives.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Telix Pharmaceuticals Q1 2026: Revenue growth, guidance reaffirmed

Telix Pharmaceuticals lifts Q1 revenue 11%, reports pipeline progress, and keeps its full-year guidance on track.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

3 ASX 200 healthcare shares to buy amid sector rout

The experts are backing these stocks for price growth.

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Healthcare Shares

Are investors taking a big gamble chasing 4DX shares higher and higher?

Investor interest in this ASX healthcare tech stock is booming.

Read more »